At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IBB iShares Biotechnology ETF
Trading 08-05 10:26:49 EDT
193.31
+3.16
+1.66%
High194.13Low191.71Vol337.55K
Open191.88D1 Closing190.15Amplitude1.27%
Mkt Cap9.57BTradable Cap9.57BTotal Shares49.50M
T/O65.17MT/O Rate0.68%Tradable Shares49.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Amgen Shares Hit Record High; Last up 6.3% at $414.61
THOMSON REUTERS  ·  17 minutes ago
Amgen Shares Hit Record High; Last up 6.3% at $414.61
Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise
THOMSON REUTERS  ·  31 minutes ago
Amgen Shares up 5% After Q2 Results Beat Estimates; FY Profit Forecast Raise
Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares
Dow Jones  ·  42 minutes ago
Dow's 500-Point Rally Led by Gains in Amgen, Nvidia Corp. Shares
Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366
THOMSON REUTERS  ·  21:14
Amgen Inc : Canaccord Genuity Raises Target Price to $384 from $366
Sector Update: Healthcare
MT Newswires Live  ·  21:01
Sector Update: Healthcare
Immuneering Expects Cash Runway to Fund Operations into 2029
Reuters  ·  19:40
Immuneering Expects Cash Runway to Fund Operations into 2029
Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)
TIPRANKS  ·  19:40
Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)
Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates
Reuters  ·  19:15
Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates
Gilead : Leerink Partners Raises Target Price to $130 from $126
THOMSON REUTERS  ·  18:16
Gilead : Leerink Partners Raises Target Price to $130 from $126
Amgen Inc : Scotiabank Raises Target Price to $450 from $385
THOMSON REUTERS  ·  17:20
Amgen Inc : Scotiabank Raises Target Price to $450 from $385
Gilead Sciences (GILD) Gets a Buy from Wells Fargo
TIPRANKS  ·  17:16
Gilead Sciences (GILD) Gets a Buy from Wells Fargo
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
TIPRANKS  ·  16:56
Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained
Street View: Gilead's HIV Strength Outshines Long-Term Competitive Worries
Reuters  ·  16:47
Street View: Gilead's HIV Strength Outshines Long-Term Competitive Worries
Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong
Dow Jones  ·  16:32
Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong
Street View: Amgen Builds Momentum with Blockbusters, Biosimilars and a Pipeline in Waiting
Reuters  ·  16:24
Street View: Amgen Builds Momentum with Blockbusters, Biosimilars and a Pipeline in Waiting
Amgen Inc : Morgan Stanley Raises Target Price to $351 from $333
THOMSON REUTERS  ·  14:30
Amgen Inc : Morgan Stanley Raises Target Price to $351 from $333
Switzerland's Sandoz H1 Net Sales Rise on Biosimilar Growth
Reuters  ·  13:08
Switzerland's Sandoz H1 Net Sales Rise on Biosimilar Growth
Radiopharm Theranostics Lifts Cap on Securities Purchase Plan to AUD10 Million
TIPRANKS  ·  12:02
Radiopharm Theranostics Lifts Cap on Securities Purchase Plan to AUD10 Million
Amgen Inc : Oppenheimer Raises Target Price to $450 from $400
THOMSON REUTERS  ·  11:10
Amgen Inc : Oppenheimer Raises Target Price to $450 from $400
Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares
TIPRANKS  ·  10:57
Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares
No data available

Introduction

Company Name.
iShares Biotechnology ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Issue price:
--